Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment has he made of the effect the cancellation of the Valneva covid-19 vaccine order during the trial of that vaccine on people (a) who are part of that trial who may or may not have received the Oxford-AstraZeneca vaccine but do not yet know which vaccine they received and (b) who wish to remain as part of that trial.

The cancellation of the Valneva supply contract does not directly impact the clinical trials which are ongoing. Clinical trial participants who received a Valneva vaccination as part of their trial will continue to be able to prove their vaccination status and will be treated as fully vaccinated in domestic settings and at the United Kingdom border.